FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lanell Peterson

Research Profile

Chemicals & Drugs

Procedures

Disorders

Physiology

Devices

Radiometry

Concepts & Ideas

Living Beings

Rats

Anatomy

Lung

Co-author Network

Publications

TOP 3
Brenda F Kurland; Kimberly H Allison; Xiaoyu Chai; Vijayakrishna K Gadi; Robert B Livingston; David A Mankoff; Lanell M Peterson; Eve T Rodler; Erin K Schubert; Jennifer M Specht; Hannah M Linden
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients.
Lanell M Peterson; Erin K Schubert; Svetlana A Stekhova; Brenda F Kurland; Hannah M Linden; Jeanne M Link; David A Mankoff
Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.
Brenda F Kurland; Jean H Lee; Hannah M Linden; Jeanne M Link; Lisa K Dunnwald; Kenneth A Krohn; Lanell M Peterson; Erin K Schubert; David A Mankoff
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lanell Peterson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Brenda F Kurland; Kimberly H Allison; Xiaoyu Chai; Vijayakrishna K Gadi; Robert B Livingston; David A Mankoff; Lanell M Peterson; Eve T Rodler; Erin K Schubert; Jennifer M Specht; Hannah M Linden
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients.
EJNMMI research 2012;2(1):34.
2011: Lanell M Peterson; Erin K Schubert; Svetlana A Stekhova; Brenda F Kurland; Hannah M Linden; Jeanne M Link; David A Mankoff
Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.
Nuclear medicine and biology 2011;38(7):969-78.
2011: Brenda F Kurland; Jean H Lee; Hannah M Linden; Jeanne M Link; Lisa K Dunnwald; Kenneth A Krohn; Lanell M Peterson; Erin K Schubert; David A Mankoff
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(10):1541-9.
2011: Hannah M Linden; Jeanne M Link; Robert B Livingston; Georgiana K Ellis; Julie R Gralow; Kenneth A Krohn; Brenda F Kurland; Thomas J Lawton; Lanell M Peterson; Philip H Petra; Erin K Schubert; Jennifer M Specht; David A Mankoff
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4799-805.
2010: Robert K Doot; Mark Muzi; Lanell M Peterson; Erin K Schubert; Julie R Gralow; Jennifer M Specht; David A Mankoff
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(4):521-7.
2008: Lanell M Peterson; David A Mankoff; Thomas Lawton; Kevin Yagle; Erin K Schubert; Svetlana Stekhova; Allen M Gown; Jeanne M Link; Timothy Tewson; Kenneth A Krohn
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(3):367-74.
2007: Robert K Doot; Lisa K Dunnwald; Erin K Schubert; Mark Muzi; Lanell M Peterson; Paul E Kinahan; Brenda F Kurland; David A Mankoff
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(6):920-5.
2007: Eric Turcotte; Linda W Wiens; John R Grierson; Lanell M Peterson; Mark H Wener; Hubert Vesselle
Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses.
BMC nuclear medicine 2007;7():3.
2006: Joseph G Rajendran; David L Schwartz; Janet O'Sullivan; Lanell M Peterson; Patrick Ng; Jeffrey Scharnhorst; John R Grierson; Kenneth A Krohn
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5435-41.
2006: Hannah M Linden; Svetlana A Stekhova; Jeanne M Link; Julie R Gralow; Robert B Livingston; Georgiana K Ellis; Philip H Petra; Lanell M Peterson; Erin K Schubert; Lisa K Dunnwald; Kenneth A Krohn; David A Mankoff
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2793-9.
2004: Joseph G Rajendran; David A Mankoff; Finbarr O'Sullivan; Lanell M Peterson; David L Schwartz; Ernest U Conrad; Alexander M Spence; Mark Muzi; D Gregory Farwell; Kenneth A Krohn
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2245-52.
2003: Hubert Vesselle; John R Grierson; Lanell M Peterson; Mark Muzi; David A Mankoff; Kenneth A Krohn
18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1482-8.
2003: Joseph G Rajendran; D C Wilson; Ernest U Conrad; Lanell M Peterson; James D Bruckner; Janet S Rasey; LK Chin; PD Hofstrand; John R Grierson; Janet F Eary; Kenneth A Krohn
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.
European journal of nuclear medicine and molecular imaging 2003;30(5):695-704.
2002: Hubert Vesselle; John R Grierson; Mark Muzi; Jeffrey M Pugsley; Rodney A Schmidt; Peter Rabinowitz; Lanell M Peterson; Eric Vallières; Douglas E Wood
In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3315-23.
2001: David A Mankoff; Lanell M Peterson; TJ Tewson; Jeanne M Link; Julie R Gralow; Michael M Graham; Kenneth A Krohn
[18F]fluoroestradiol radiation dosimetry in human PET studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(4):679-84.
2000: Michael M Graham; Lanell M Peterson; R M Hayward
Comparison of simplified quantitative analyses of FDG uptake.
Nuclear medicine and biology 2000;27(7):647-55.
1999: TJ Tewson; David A Mankoff; Lanell M Peterson; I Woo; Philip H Petra
Interactions of 16alpha-[18F]-fluoroestradiol (FES) with sex steroid binding protein (SBP).
Nuclear medicine and biology 1999;26(8):905-13.
1999: David A Mankoff; Anthony F Shields; Jeanne M Link; Michael M Graham; Mark Muzi; Lanell M Peterson; Janet F Eary; Kenneth A Krohn
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):614-24.
1998: Michael M Graham; Lanell M Peterson; Mark Muzi; B B Graham; Alexander M Spence; Jeanne M Link; Kenneth A Krohn
1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(10):1805-10.
1997: Michael M Graham; Lanell M Peterson; Jeanne M Link; M L Evans; Janet S Rasey; W J Koh; James H Caldwell; Kenneth A Krohn
Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1631-6.
1996: Janet S Rasey; Wui-Jin Koh; M L Evans; Lanell M Peterson; Thomas K Lewellen; Michael M Graham; Kenneth A Krohn
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.
International journal of radiation oncology, biology, physics 1996;36(2):417-28.
1996: Keith J Stelzer; Wui-Jin Koh; Lanell M Peterson; TW Griffin
Effect of high-dose pentoxifylline on acute radiation-induced lung toxicity in a rat lung perfusion model.
International journal of radiation oncology, biology, physics 1996;34(1):111-5.
1995: Wui-Jin Koh; K S Bergman; Janet S Rasey; Lanell M Peterson; M L Evans; Michael M Graham; John R Grierson; KL Lindsley; Thomas K Lewellen; Kenneth A Krohn
Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.
International journal of radiation oncology, biology, physics 1995;33(2):391-8.
1995: Wui-Jin Koh; Keith J Stelzer; Lanell M Peterson; B L Staker; W F Ward; Kenneth J Russell; TW Griffin
Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats.
International journal of radiation oncology, biology, physics 1995;31(1):71-7.
1992: Lanell M Peterson; M L Evans; K L Thomas; Michael M Graham
Vascular response to fractionated irradiation in the rat lung.
Radiation research 1992;131(2):224-6.
1992: Lanell M Peterson; M L Evans; Michael M Graham; Janet F Eary; D D Dahlen
Vascular response to radiation injury in the rat lung.
Radiation research 1992;129(2):139-48.